β-lactam resistance in Gram-negative Pathogens isolated from animals

Current Pharmaceutical Design

Volumn 19, Issue 2, 2013, Pages 239-249

  Trott, Darren ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antimicrobial resistance; Companion animals; Escherichia coli; Extended spectrum; Livestock; ST131; lactamases

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ASPOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFACETRILE; CEFALEXIN; CEFAPIRIN; CEFAZOLIN; CEFOPERAZONE; CEFQUINOME; CEFTIOFUR; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; DICLOXACILLIN; HETACILLIN; MECILLINAM; NAFCILLIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; AQUACULTURE; ARTICLE; BACTERIOPHAGE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FOOD INDUSTRY; GRAM NEGATIVE BACTERIUM; LIVESTOCK; LONGITUDINAL STUDY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH;

EID: 84877930938     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213804070339     Document Type: Article

References (146)

1. Prescott JF. Antimicrobial use in food and companion animals. Anim Health Res Rev 2008; 9: 127-33.
2. Angulo FJ, Nunnery JA, Bair HD. Antimicrobial resistance in zoonotic enteric pathogens. Rev Sci Tech 2004; 23: 485-96.
3. Hunter PA, Dawson S, French GL, et al. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother; 65 Suppl 1: i3-17.
4. Giguere S, Prescott JF, Baggot JD, Walker RD, Dowling PM. Antimicrobial Therapy in Veterinary Medicine. Ames, IA: Blackwell Publishing 2006.
5. McReynolds JL, Caldwell DY, McElroy AP, Hargis BM, Caldwell DJ. Antimicrobial residue detection in chicken yolk samples following administration to egg-producing chickens and effects of residue detection on competitive exclusion culture (PREEMPT) establishment. J Agric Food Chem 2000; 48: 6435-8.
6. Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004; 54: 321-32.
7. Dolejska M, Bierosova B, Kohoutova L, Cizek A. Antibioticresistant Salmonella and Escherichia coli isolates with integrons and extended-spectrum beta-lactamases in surface water and sympatric black-headed gulls. J Appl Microbiol 2009; 106: 1941-1950.
8. Li XZ, Mehrotra M, Ghimire S, Adewoye L. beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet Microbiol 2007; 121: 197-214.
9. Smet A, Martel A, Persoons D, et al. Broad-spectrum betalactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev 2010; 34: 295-316.
10. Tollefson L, Morris D, Boland C, Kay J. In: F. M. Aerestrup, Ed. Antimicrobial resistance of animal origin. Washington D.C.: ASM Press. 2006, pp. 361-374.
11. Hornish RE, Kotarski SF. Cephalosporins in veterinary medicine-ceftiofur use in food animals. Curr Top Med Chem 2002; 2: 717-31.
12. Jordan D, Chin JJ, Fahy VA, et al. Antimicrobial use in the Australian pig industry: results of a national survey. Aust Vet J 2009; 87: 222-9.
13. CTX-M-1 between commensal Escherichia coli in pigs and farm workers. Antimicrob Agents Chemother 2009; 53: 1709-11.
14. McReynolds JL, Caldwell DY, Barnhart ET, et al. The effect of in ovo or day-of-hatch subcutaneous antibiotic administration on competitive exclusion culture (PREEMPT) establishment in neonatal chickens. Poult. Sci. 2000; 79: 1524-30.
15. McEwan A, Aerestrup FM, Jordan D. In: F. M. Aerestrup, Ed. Antimicrobial resistance in bacteria of animal origin. Washington D.C.: ASM Press. 2006, pp. 397-414.
16. Do NT, Cu HP, Nguyen NN, et al. Antimicrobial resistance phenotypes of ETEC isolates from piglets with diarrhea in North Vietnam. Ann N Y Acad Sci 2006; 1081: 543-5.
17. Weese JS. Antimicrobial resistance in companion animals. Anim Health Res Rev 2008; 9: 169-176.
18. Sanchez S, McCrackin Stevenson MA, Hudson CR, et al. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 2002; 40: 3586-95.
19. Sidjabat HE, Townsend KM, Hanson ND, et al. Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J Antimicrob Chemother 2006; 57: 840-8.
20. Gibson JS, Morton JM, Cobbold RN, Filippich LJ, Trott DJ. Risk factors for multidrug-resistant Escherichia coli rectal colonization of dogs on admission to a veterinary hospital. Epidemiol Infect. 2011; 139: 197-205.
21. Gibson JS, Morton JM, Cobbold RN, et al. Multidrug-resistant E. coli and Enterobacter extraintestinal infection in 37 dogs. J Vet Intern Med 2008; 22: 844-50.
22. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis. 2006; 43: e101-108.
23. Platell JL, Cobbold RN, Johnson JR, Trott DJ. Clonal group distribution of fluoroquinolone resistant Escherichia coli among Humans and Companion Animals in Australia. J Antimicrob Chemother 2010; 65: 1936-8.
24. Espie E, De Valk H, Vaillant V, et al. An outbreak of multidrugresistant Salmonella enterica serotype Newport infections linked to the consumption of imported horse meat in France. Epidemiol Infect 2005; 133: 373-6.
25. Akinbowale OL, Peng H, Grant P, Barton MD. Antibiotic and heavy metal resistance in motile aeromonads and pseudomonads from rainbow trout (Oncorhynchus mykiss) farms in Australia. Int J. Antimicrob Agents 2007; 30: 177-82.
26. Bradford PA, Petersen PJ, Fingerman IM, White DG. Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. J Antimicrob Chemother 1999; 44: 607-610.
27. Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and Human Multidrug-Resistant, Cephalosporin-Resistant Salmonella Isolates Expressing a Plasmid-Mediated CMY-2 AmpC II-lactamase. Antimicrob Agents Chemother 2000; 44: 2777-2783.
28. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001; 45: 2716-22.
29. Gupta A, Fontana J, Crowe C, et al. Emergence of multidrugresistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003; 188: 1707-16.
30. Pitout JD, Reisbig MD, Mulvey M, et al. Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC beta-lactamase, CMY-2. J Clin Microbiol 2003; 41: 4578-4582.
31. Srinivasan V, Nguyen LT, Headrick SI, Murinda SE, Oliver SP. Antimicrobial resistance patterns of Shiga toxin-producing Escherichia coli O157:H7 and O157:H7-from different origins. Microb Drug Resist 2007; 13: 44-51.
32. Srinivasan V, Gillespie BE, Lewis MJ, et al. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis. Vet Microbiol 2007; 124: 319-28.
33. Frye JG, Fedorka-Cray PJ. Prevalence, distribution and characterisation of ceftiofur resistance in Salmonella enterica isolated from animals in the USA from 1999 to 2003. Int J Antimicrob Agents 2007; 30: 134-42.
34. Frye JG, Fedorka-Cray PJ, Jackson CR, Rose M. Analysis of Salmonella enterica with reduced susceptibility to the thirdgeneration cephalosporin ceftriaxone isolated from U.S. cattle during 2000-2004. Microb Drug Resist 2008; 14: 251-8.
35. Zhao S, McDermott PF, White DG, et al. Characterization of multidrug resistant Salmonella recovered from diseased animals. Vet Microbiol 2007; 123: 122-32.
36. Daniels JB, Call DR, Hancock D, et al. Role of ceftiofur in selection and dissemination of blaCMY-2-mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle. Appl Environ Microbiol 2009; 75: 3648-55.
37. Tragesser LA, Wittum TE, Funk JA, Winokur PL, Rajala-Schultz PJ. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am J Vet Res 2006; 67: 1696-700.
38. CMY-2 within a pulsed-field gel electrophoresisdefined clade of Salmonella enterica serovar Typhimurium. Appl Environ Microbiol 2010; 76: 69-74.
39. Jiang X, Yang H, Dettman B, Doyle MP. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathogen Dis 2006; 3: 355-65.
40. Singer RS, Patterson SK, Wallace RL. Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl Environ Microbiol 2008; 74: 6956-62.
41. Alali WQ, Scott HM, Norby B, Gebreyes W, Loneragan GH. Quantification of the bla(CMY-2) in feces from beef feedlot cattle administered three different doses of ceftiofur in a longitudinal controlled field trial. Foodborne Pathogen Dis 2009; 6: 917-24.
42. Rankin SC, Aceto H, Cassidy J, et al. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40: 4679-84.
43. CMY-2 Salmonella Typhimurium in Mexico. J Antimicrob Chemother 2007; 60: 398-401.
44. Zhao S, Blickenstaff K, Glenn A, et al. beta-Lactam resistance in Salmonella strains isolated from retail meats in the United States by the National Antimicrobial Resistance Monitoring System between 2002 and 2006. Appl Environ Microbiol 2009; 75: 7624-30.
45. Smet A, Martel A, Persoons D, et al. Diversity of extendedspectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrob Agents Chemother 2008; 52: 1238-43.
46. Smith MG, Jordan D, Chapman TA, et al. Antimicrobial resistance and virulence gene profiles in multi-drug resistant enterotoxigenic Escherichia coli isolated from pigs with post-weaning diarrhoea. Vet Microbiol 2010; 145: 299-307.
47. Smith MG, Chapman TA, Jordan D, et al. In: Australian Pig Science Association, Manipulating Pig Production XI. Perth, Western Australia: Ed. Patterson, J. E. Barker, J. A. 2007, p. 59.
48. Li L, Jiang ZG, Xia LN, et al. Characterization of antimicrobial resistance and molecular determinants of beta-lactamase in Escherichia coli isolated from chickens in China during 1970-2007. Vet Microbiol 2010; 144: 505-10.
49. Mulvey MR, Susky E, McCracken M, Morck DW, Read RR. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet Microbiol 2009; 134: 279-87.
50. Dierikx C, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol 2010; 145: 273-8.
51. Brinas L, Moreno MA, Zarazaga M, et al. Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecalsample isolates from healthy chickens. Antimicrob Agents Chemother 2003; 47: 2056-8.
52. Blanc V, Cortes P, Mesa RJ, et al. Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms. Int J Antimicrob Agents 2008; 31: 76-8.
53. Liu JH, Wei SY, Ma JY, et al. Detection and characterisation of CTX-M and CMY-2 beta-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. Int J Antimicrob Agents 2007; 29: 576-81.
54. Girlich D, Poirel L, Carattoli A, et al. Extended-spectrum betalactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France. Appl Environ Microbiol 2007; 73: 4681-5.
55. Costa D, Vinue L, Poeta P, et al. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers. Vet Microbiol 2009; 138: 339-44.
56. Bortolaia V, Guardabassi L, Trevisani M, et al. High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks. Antimicrob Agents Chemother 2010; 54: 1623-6.
57. Warren RE, Ensor VM, O'Neill P, et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2008; 61: 504-8.
58. Yuan L, Liu JH, Hu GZ, et al. Molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolates from chickens in Henan Province, China. J Med Microbiol 2009; 58: 1449-53.
59. Rodriguez I, Barownick W, Helmuth R, et al. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofurresistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. J Antimicrob Chemother 2009; 64: 301-9.
60. Escudero E, Vinue L, Teshager T, Torres C, Moreno MA. Resistance mechanisms and farm-level distribution of fecal Escherichia coli isolates resistant to extended-spectrum cephalosporins in pigs in Spain. Res Vet Sci 2010; 88: 83-7.
61. Wu S, Chouliara E, Hasman H, et al. Detection of a single isolate of CTX-M-1-producing Escherichia coli from healthy pigs in Denmark. J Antimicrob Chemother 2008; 61: 747-9.
62. Tian GB, Wang HN, Zou LK, et al. Detection of CTX-M-15, CTXM-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathogen Dis 2009; 6: 297-304.
63. Jorgensen CJ, Cavaco LM, Hasman H, Emborg HD, Guardabassi L. Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur. J Antimicrob Chemother 2007; 59: 1040-2.
64. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob Agents Chemother 2008; 52: 3612-6.
65. Doi Y, Paterson DL, Egea P, et al. Extended-spectrum and CMYtype beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010; 16: 33-8.
66. Johnson TJ, Wannemuehler Y, Johnson SJ, et al. Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol 2008; 74: 7043-50.
67. Johnson JR, Sannes MR, Croy C, et al. Antimicrobial drugresistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 2007; 13: 838-46.
68. Vincent C, Boerlin P, Daignault D, et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis.; 16: 88-95.
69. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873-80.
70. Randall L, Wu G, Phillips N, et al. Virulence genes in bla(CTX-M) Escherichia coli isolates from chickens and humans. Res Vet Sci 2012; 93: 23-7.
71. Mora A, Herrera A, Mamani R, et al. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 2010; 76: 6991-7.
72. Potter A, Gerdts V, Littel-van den Hurk SD. Veterinary vaccines: alternatives to antibiotics? Anim Health Res Rev 2008; 9: 187-99.
73. Mohler VL, Heithoff DM, Mahan MJ, et al. Cross-protective immunity conferred by a DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in calves challenged with Salmonella serovar Newport. Vaccine 2008; 26: 1751-8.
74. Mizuno T, McLennan M, Trott D. Intramuscular vaccination of young calves with a Salmonella Dublin metabolic-drift mutant provides superior protection to oral delivery. Vet Res 2008; 39: 26.
75. Fairbrother JM, Nadeau E, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev 2005; 6: 17-39.
76. Aarestrup FM, Oliver Duran C, Burch DG. Antimicrobial resistance in swine production. Anim Health Res Rev 2008; 9: 135-48.
77. Gyles CL. Antimicrobial resistance in selected bacteria from poultry. Anim Health Res Rev 2008; 9: 149-58.
78. Dziva F, Stevens MP. Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts. Avian Pathol 2008; 37: 355-66.
79. Yaguchi K, Ohgitani T, Noro T, Kaneshige T, Shimizu Y. Vaccination of chickens with liposomal inactivated avian pathogenic Escherichia coli (APEC) vaccine by eye drop or coarse spray administration. Avian Dis 2009; 53: 245-9.
80. Kariyawasam S, Wilkie BN, Gyles CL. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli. Avian Dis 2004; 48: 287-99.
81. Kariyawasam S, Wilkie BN, Hunter DB, Gyles CL. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis 2002; 46: 668-78.
82. Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci USA 2010; 107: 9072-7.
83. Feria C, Ferreira E, Correia JD, Goncalves J, Canica M. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J Antimicrob Chemother 2002; 49: 77-85.
84. Carattoli A, Lovari S, Franco A, et al. Extended-spectrum betalactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 833-5.
85. Murphy C, Reid-Smith RJ, Prescott JF, et al. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study. Can Vet J 2009; 50: 1047-53.
86. Wedley AL, Maddox TW, Westgarth C, et al. Prevalence of antimicrobial-resistant Escherichia coli in dogs in a cross-sectional, community-based study. Vet Rec 2011; 168: 354.
87. Ma J, Zeng Z, Chen Z, et al. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob Agents Chemother 2009; 53: 519-24.
88. Hanson ND, Moland ES, Hossain A, et al. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J Antimicrob Chemother 2002; 49: 1011-4.
89. Hopkins KL, Batchelor MJ, Liebana E, Deheer-Graham AP, Threlfall EJ. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales. Int J Antimicrob Agents 2006; 28: 180-92.
90. Sidjabat HE, Chin JJ, Chapman T, et al. Colonisation dynamics and virulence of two clonal groups of multidrug-resistant Escherichia coli isolated from dogs. Microbes Infect 2009; 11: 100-7.
91. Gibson JS, Cobbold RN, Trott DJ. Characterization of multidrugresistant Escherichia coli isolated from extraintestinal clinical infections in animals. J Med Microbiol 2010; 59: 592-8.
92. Sidjabat HE, Hanson ND, Smith-Moland E, et al. Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogs. J Med Microbiol 2007; 56: 426-34.
93. Teshager T, Dominguez L, Morenzo MA, et al. Isolation of a SHV-12 ß-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections. Antimicrob Agents Chemother 2000; 44: 3483-3484.
94. Gibson JS, Cobbold RN, Heisig P, et al. Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals. Vet. Microbiol 2010; 143: 329-36.
95. Harada K, Morimoto E, Kataoka Y, Takahashi T. Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels. Acta Vet Scand 2011; 53: 11.
96. Costa D, Poeta P, Saenz Y, et al. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet Microbiol 2008; 127: 97-105.
97. Moreno A, Bello H, Guggiana D, Dominguez M, Gonzalez G. Extended-spectrum beta-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet Microbiol 2008; 129: 203-8.
98. Lim SK, Lee HS, Nam HM, Jung SC, Bae YC. CTX-M-type betalactamase in Escherichia coli isolated from sick animals in Korea. Microb Drug Resist 2009; 15: 139-42.
99. Sun Y, Zeng Z, Chen S, et al. High prevalence of bla extendedspectrum beta(CTX-M)-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 2010; 16: 1475-81.
100. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martinez-Martinez L. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog. Antimicrob Agents Chemother 2009; 53: 327-8.
101. Ewers C, Grobbel M, Stamm I, et al. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-betalactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother; 65: 651-60.
102. Platell JL, Cobbold RN, Johnson JR, et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother 2011; 55: 3782-7.
103. Schink AK, Kadlec K, Schwarz S. Analysis of blaCTX-M-carrying plasmids from Escherichia coli isolates collected in the BfTGermVet study. Appl Environ Microbiol 2011; 77: 7142-6.
104. Trott DJ, Filippich LJ, Bensink JC, et al. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. J Med Microbiol 2004; 53: 439-43.
105. Platell JL, Cobbold RN, Johnson JR, Trott DJ. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 2010; 65: 1936-8.
106. Gibson JS, Morton JM, Cobbold RN, Filippich LJ, Trott DJ. Risk factors for dogs becoming rectal carriers of multidrug-resistant Escherichia coli during hospitalization. Epidemiol Infect 2011; 139: 1511-21.
107. Damborg P, Gaustad IB, Olsen JE, Guardabassi L. Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin. Vet Microbiol 2011; 151: 404-8.
108. Sidjabat HE, Townsend KM, Lorentzen M, et al. Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J Med Microbiol 2006; 55: 1125-34.
109. Prescott JF, Hanna WJB, Reld-Smith R, Drost K. Antimicrobial drug use and resistance in dogs. Can Vet J 2002; 43: 107-116.
110. Hubka P, Boothe DM. In vitro susceptibility of canine and feline Escherichia coli to fosfomycin. Vet Microbiol 2011; 149: 277-82.
111. Thompson MF, Totsika M, Schembri MA, et al. Experimental colonization of the canine urinary tract with the asymptomatic bacteriuria Escherichia coli strain 83972. Vet Microbiol 2011; 147: 205-8.
112. Vo AT, van Duijkeren E, Fluit AC, Gaastra W. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses. Vet Microbiol 2007; 124: 248-55.
113. CTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre. J Antimicrob Chemother 2011; 66: 757-64.
114. Maddox TW, Clegg PD, Diggle PJ, et al. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus. Equine Vet J 2012; 44: 289-96.
115. Maddox TW, Pinchbeck GL, Clegg PD, et al. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: Risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses. Equine Vet J 2012; 44: 298-303.
116. Damborg P, Marskar P, Baptiste KE, Guardabassi L. Faecal shedding of CTX-M-producing Escherichia coli in horses receiving broad-spectrum antimicrobial prophylaxis after hospital admission. Vet Microbiol 2012; 154: 2784-90.
117. Dargatz DA, Traub-Dargatz JL. Multidrug-resistant Salmonella and nosocomial infections. Vet Clin North Am Equine Pract 2004; 20: 587-600.
118. Schott HC, Ewart SL, Walker RD, et al. An outbreak of salmonellosis among horses at a veterinary teaching hospital. J Am Vet Med Assoc 2001; 218: 1152-9.
119. Tillotson K, Savage CJ, Salman MD, et al. Outbreak of Salmonella infantis infection in a large animal veterinary teaching hospital. J Am Vet Med Assoc 1997; 211: 1554-7.
120. van Duijkeren E, Wannet WJ, Heck ME, et al. Sero types, phage types and antibiotic susceptibilities of Salmonella strains isolated from horses in The Netherlands from 1993 to 2000. Vet Microbiol 2002; 86: 203-12.
121. Ernst NS, Hernandez JA, MacKay RJ, et al. Risk factors associated with fecal Salmonella shedding among hospitalized horses with signs of gastrointestinal tract disease. J Am Vet Med Assoc 2004; 225: 275-81.
122. Ward MP, Brady TH, Couetil LL, et al. Investigation and control of an outbreak of salmonellosis caused by multidrug-resistant Salmonella typhimurium in a population of hospitalized horses. Vet Microbiol 2005; 107: 233-40.
123. Dallap Schaer BL, Aceto H, Rankin SC. Outbreak of salmonellosis caused by Salmonella enterica serovar Newport MDR-AmpC in a large animal veterinary teaching hospital. J Vet Intern Med 2010; 24: 1138-46.
124. Rankin SC, Whichard JM, Joyce K, et al. Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC. J Clin Microbiol 2005; 43: 5792-3.
125. Alinovi CA, Ward MP, Couetil LL, Wu CC. Risk factors for fecal shedding of Salmonella from horses in a veterinary teaching hospital. Prev Vet Med 2003; 60: 307-17.
126. Ahmed AM, Motoi Y, Sato M, et al. Zoo animals as reservoirs of Gram-negative bacteria harboring integrons and antimicrobial resistance genes. Appl Environ Microbiol 2007; 73: 6686-90.
127. Pinto L, Radhouani H, Coelho C, et al. Genetic detection of extended-spectrum beta-lactamase-producing Escherichia coli from birds of prey from Serra da Estrela Natural Reserve in Portugal. Appl Environ Microbiol 2010; 76: 4118-20.
128. Poeta P, Radhouani H, Igrejas G, et al. Seagulls of the Berlengas natural reserve of Portugal as carriers of fecal Escherichia coli harboring CTX-M and TEM extended-spectrum beta-lactamases. Appl Environ Microbiol 2008; 74: 7439-41.
129. Sato M, Ahmed AM, Noda A, et al. Isolation and molecular characterization of multidrug-resistant Gram-negative bacteria from imported flamingos in Japan. Acta Vet Scand 2009; 51: 46.
130. Carneiro C, Araujo C, Goncalves A, et al. Detection of CTX-M-14 and TEM-52 extended-spectrum beta-lactamases in fecal Escherichia coli isolates of captive ostrich in Portugal. Foodborne Pathogen Dis 2010; 7: 991-4.
131. Literak I, Dolejska M, Janoszowska D, et al. Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of Poland. Appl Environ Microbiol 2010; 76: 8126-34.
132. Dolejska M, Frolkova P, Florek M, et al. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J Antimicrob Chemother 2011; 66: 2784-90.
133. Bonnedahl J, Drobni M, Gauthier-Clerc M, et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PloS One 2009; 4: e5958.
134. Poeta P, Radhouani H, Pinto L, et al. Wild boars as reservoirs of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli of different phylogenetic groups. J Basic Microbiol 2009; 49: 584-8.
135. Literak I, Dolejska M, Radimersky T, et al. Antimicrobial-resistant faecal Escherichia coli in wild mammals in central Europe: multiresistant Escherichia coli producing extended-spectrum betalactamases in wild boars. J Appl Microbiol 2010; 108: 1702-11.
136. Guenther S, Grobbel M, Beutlich J, et al. Detection of pandemic B2-O25-ST131 Escherichia coli harbouring the CTX-M-9 extended-spectrum beta-lactamase type in a feral urban brown rat (Rattus norvegicus). J Antimicrob Chemother 2010; 65: 582-4.
137. Guenther S, Grobbel M, Heidemanns K, et al. First insights into antimicrobial resistance among faecal Escherichia coli isolates from small wild mammals in rural areas. Sci Total Environ 2010; 408: 3519-22.
138. Akinbowale OL, Peng H, Barton MD. Antimicrobial resistance in bacteria isolated from aquaculture sources in Australia. J Appl Microbiol 2006; 100: 1103-13.
139. Hatha M, Vivekanandhan AA, Joice GJ, Christol. Antibiotic resistance pattern of motile aeromonads from farm raised fresh water fish. Int J Food Microbiol 2005; 98: 131-4.
140. Mirand CD, Zemelman R. Antimicrobial multiresistance in bacteria isolated from freshwater Chilean salmon farms. Sci Total Environ 2002; 293: 207-18.
141. McIntosh D, Cunningham M, Ji B, et al. Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254. J Antimicrob Chemother 2008; 61: 1221-8.
142. Saavedra MJ, Guedes-Novais S, Alves A, et al. Resistance to betalactam antibiotics in Aeromonas hydrophila isolated from rainbow trout (Oncorhynchus mykiss). Int Microbiol 2004; 7: 207-11.
143. Sousa M, Torres C, Barros J, et al. Gilthead Seabream (Sparus aurata) as carriers of SHV-12 and TEM-52 extended-spectrum beta-lactamases-containing Escherichia coli isolates. Foodborne Pathogen Dis 2011; 8: 1139-41.
144. Osburn B, Scott C, Gibbs P. One world-one medicine-one health: emerging veterinary challenges and opportunities. Rev Sci Tech 2009; 28: 481-6.
145. Cribb A, Buntain B. Innovation in veterinary medical education: the concept of 'One World, One Health' in the curriculum of the Faculty of Veterinary Medicine at the University of Calgary. Rev Sci Tech 2009; 28: 753-62.
146. Fenwick SG, Robertson L, Wilks CR. Integrating the issues of global and veterinary public health into the veterinary education curriculum: an Australian perspective. Rev Sci Tech 2009; 28: 709-18.